Revisiting cardiopulmonary exercise testing applications in heart failure: Aligning evidence with clinical practice

Exercise and Sport Sciences Reviews

Volumn 42, Issue 4, 2014, Pages 153-160

  Arena, Ross ^a   Guazzi, Marco ^b   Cahalin, Lawrence P ^c   Myers, Jonathan ^d  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Class recommendation; Diagnosis; Exercise testing; Expired gas; Level of evidence; Prognosis

Indexed keywords

EVIDENCE BASED MEDICINE; EXERCISE TEST; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; LUNG FUNCTION TEST; OXYGEN CONSUMPTION; PRACTICE GUIDELINE; PROGNOSIS; TREATMENT OUTCOME;

EVIDENCE-BASED MEDICINE; EXERCISE TEST; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; OXYGEN CONSUMPTION; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME;

EID: 84925884730     PISSN: 00916331     EISSN: 15383008     Source Type: Journal    
DOI: 10.1249/JES.0000000000000022     Document Type: Article

References (38)

1. Arena R, Guazzi M, Myers J, Ann PM. Prognostic characteristics of cardiopulmonary exercise testing in heart failure: comparing American and European models. Eur. J. Cardiovasc. Prev. Rehabil. 2005; 12 (6): 562-7.
2. Arena R, Guazzi M, Myers J, Grinnan D, Forman DE, Lavie CJ. The emerging role of cardiopulmonary exercise testing in the assessment of suspected or confirmed pulmonary arterial hypertension and secondary pulmonary hypertension. Exp. Rev. Respir. Med. 2011; 5:281-93.
3. Arena R, Myers J, Abella J, Peberdy MA, Bensimhon D, Chase P, Guazzi M. Development of a ventilatory classification system in patients with heart failure. Circulation. 2007; 115 (18): 2410-7.
4. Arena R, Myers J, Abella J, Peberdy MA, Bensimhon D, Chase P, Guazzi M. The prognostic value of the heart rate response during exercise and recovery in patients with heart failure: influence of beta-blockade. Int. J. Cardiol. 2010; 138 (2): 166-73.
5. Arena R, Myers J, Abella J, et al. Defining the optimal prognostic window for cardiopulmonary exercise testing in patients with heart failure. Circ. Heart Fail. 2010; 3 (3): 405-11.
6. Arena R, Myers J, Aslam S, Varughese EB, Peberdy MA. Technical considerations related to the minute ventilation/carbon dioxide output slope in patients with heart failure. Chest. 2003; 124 (2): 720-7.
7. 2 slope in patients with heart failure: a prognostic comparison. Am. Heart J. 2004; 147 (2): 354-60.
8. Arena R, Myers J, Guazzi M. The clinical and research applications of aerobic capacity and ventilatory efficiency in heart failure: an evidencebased review. Heart Fail. Rev. 2008; 13 (2): 245-69.
9. Arena RA, Guazzi M, Myers J, Abella J. The prognostic value of ventilatory efficiency with beta-blocker therapy in heart failure. Med. Sci. Sports Exerc. 2007; 39 (2): 213-9.
10. Arena R, Guazzi M, Myers J. Prognostic value of end-tidal carbon dioxide during exercise testing in heart failure. Int. J. Cardiol. 2007; 117 (1): 103-8.
11. Arena R, Guazzi M, Myers J, Peberdy MA. Prognostic value of heart rate recovery in patients with heart failure. Am. Heart J. 2006; 151 (4): 851.
12. Arena R, Myers J, Abella J, Peberdy MA. Influence of heart failure etiology on the prognostic value of peak oxygen consumption and minute ventilation/ carbon dioxide production slope. Chest. 2005; 128 (4): 2812-7.
13. Arena R, Myers J, Abella J, et al. The partial pressure of resting end-tidal carbon dioxide predicts major cardiac events in patients with systolic heart failure. Am. Heart J. 2008; 156 (5): 982-8.
14. Arena R, Myers J, Guazzi M. Cardiopulmonary exercise testing is a core assessment for patients with heart failure. Congest. Heart Fail. 2011; 17 (3): 115-9.
15. Balady GJ, Arena R, Sietsema K, et al. Clinician's guide to cardiopulmonary exercise testing in adults. A scientific statement from the American Heart Association. Circulation. 2010; 122 (2): 191-225.
16. Cahalin LP, Chase P, Arena R, et al. A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients with heart failure. Heart Fail. Rev. 2013; 18 (1): 79-94.
17. Chase P, Arena R, Myers J, et al. Relation of the prognostic value of ventilatory efficiency to body mass index in patients with heart failure. Am. J. Cardiol. 2008; 101 (3): 348-52.
18. Chase P, Arena R, Myers J, et al. Prognostic usefulness of dyspnea versus fatigue as reason for exercise test termination in patients with heart failure. Am. J. Cardiol. 2008; 102 (7): 879-82.
19. Gibbons RJ, Balady GJ, Beasley JW, et al. ACC/AHA guidelines for exercise testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J. Am. Coll. Cardiol. 1997; 30 (1): 260-311.
20. Gibbons RJ, Balady GJ, Timothy BJ, et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J. Am. Coll. Cardiol. 2002; 40 (8): 1531-40.
21. Gibbons RJ, Smith S, Antman E. American College of Cardiology/ American Heart Association clinical practice guidelines: Part I: where do they come from? Circulation. 2003; 107 (23): 2979-86.
22. Guazzi M, Adams V, Conraads V, et al. EACPR/AHA scientific statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Circulation. 2012; 126 (18): 2261-74.
23. Guazzi M, Arena R. The impact of pharmacotherapy on the cardiopulmonary exercise test response in patients with heart failure: a mini review. Curr. Vasc. Pharmacol. 2009; 7 (4): 557-69.
24. Guazzi M, Myers J, Peberdy MA, Bensimhon D, Chase P, Arena R. Cardiopulmonary exercise testing variables reflect the degree of diastolic dysfunction in patients with heart failure-normal ejection fraction. J. Cardiopulm. Rehabil. Prev. 2010; 30 (3): 165-72.
25. Guazzi M, Myers J, Peberdy MA, Bensimhon D, Chase P, Arena R. Ventilatory efficiency and dyspnea on exertion improvements are related to reduced pulmonary pressure in heart failure patients receiving Sildenafil. Int. J. Cardiol. 2010; 144 (3): 410-2.
26. Guazzi M, Arena R, Ascione A, Piepoli M, Guazzi MD. Exercise oscillatory breathing and increased ventilation to carbon dioxide production slope in heart failure: an unfavorable combination with high prognostic value. Am. Heart J. 2007; 153 (5): 859-67.
27. Guazzi M, Arena R, Myers J. Comparison of the prognostic value of cardiopulmonary exercise testing between male and female patients with heart failure. Int. J. Cardiol. 2006; 113 (3): 395-400.
28. Guazzi M, Galie N. Pulmonary hypertension in left heart disease. Eur. Respir. Rev. 2012; 21 (126): 338-46.
29. Guazzi M, Myers J, Arena R. Cardiopulmonary exercise testing in the clinical and prognostic assessment of diastolic heart failure. J. Am. Coll. Cardiol. 2005; 46 (10): 1883-90.
30. Guazzi M, Myers J, Peberdy MA, Bensimhon D, Chase P, Arena R. Exercise oscillatory breathing in diastolic heart failure: prevalence and prognostic insights. Eur. Heart J. 2008; 29 (22): 2751-9.
31. Guazzi M, Vicenzi M, Arena R. Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study. Eur. J. Heart Fail. 2012; 14 (1): 82-90.
32. Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009; 119 (14): e391-479.
33. Lavie CJ, Cahalin LP, Chase P, et al. The impact of cardiorespiratory fitness on the obesity paradox in patients with heart failure. Mayo Clin. Proc. 2013; 88 (3): 251-8.
34. Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation. 1991; 83 (3): 778-86.
35. Myers J, Arena R, Dewey F, et al. A cardiopulmonary exercise testing score for predicting outcomes in patients with heart failure. Am. Heart J. 2008; 156 (6): 1177-83.
36. Myers J, Oliveira R, Dewey F, et al. Validation of a cardiopulmonary exercise test score in heart failure. Circ. Heart Fail. 2013; 6 (2): 211-8.
37. O'Neill JO, Young JB, Pothier CE, Lauer MS. Peak oxygen consumption as a predictor of death in patients with heart failure receiving betablockers. Circulation. 2005; 111 (18): 2313-8.
38. Van Tassell BW, Arena RA, Toldo S, et al. Enhanced interleukin-1 activity contributes to exercise intolerance in patients with systolic heart failure. PLoS One. 2012; 7 (3): e33438.